Circulating anticoagulant in disseminated lupus erythematosus. Proposed mode of action.
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000097:blood*; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D001923:Brain Chemistry; D005165:Factor V / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D006801:Humans; D007223:Infant; D008168:Lung / Q000737:chemistry; D008180:Lupus Erythematosus, Systemic / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010743:Phospholipids / Q000378:metabolism; D011516:Prothrombin / Q000032:analysis; D013925:Thromboplastin
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D010743:Phospholipids; D005165:Factor V; D011516:Prothrombin; D005170:Factor X; D013925:Thromboplastin